160 related articles for article (PubMed ID: 2009916)
21. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.
Arko-Mensah J; Julián E; Singh M; Fernández C
Scand J Immunol; 2007 Feb; 65(2):148-57. PubMed ID: 17257219
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
[TBL] [Abstract][Full Text] [Related]
23. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
Rastogi N; Cadou S; Hellio R
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.
Flesch I; Kaufmann SH
J Immunol; 1987 Jun; 138(12):4408-13. PubMed ID: 3108389
[TBL] [Abstract][Full Text] [Related]
25. Antigen presentation by dendritic cells provides optimal stimulation for the production of interleukin (IL) 2, IL 4 and interferon-gamma by allogeneic T cells.
Ellis J; Chain BM; Davies DH; Ibrahim MA; Katz DR; Kaye PM; Lightstone E
Eur J Immunol; 1991 Nov; 21(11):2803-9. PubMed ID: 1834471
[TBL] [Abstract][Full Text] [Related]
26. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
27. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
Stout RD; Bottomly K
J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
29. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
32. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
[TBL] [Abstract][Full Text] [Related]
33. In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions.
Maes H; Cocito C
J Cancer Res Clin Oncol; 1996; 122(12):727-34. PubMed ID: 8954170
[TBL] [Abstract][Full Text] [Related]
34. Alteration of the immune response during cancer development and prevention by administration of a mycobacterial antigen.
Maes H; Taper H; Cocito C
Scand J Immunol; 1995 Jan; 41(1):53-64. PubMed ID: 7824889
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of cytokines during tumour development in mice immunized with the mycobacterial antigen complex A60.
Maes H; Cocito C
Scand J Immunol; 1996 Oct; 44(4):369-74. PubMed ID: 8845030
[TBL] [Abstract][Full Text] [Related]
36. A novel monoclonal antibody against A60 antigen of Mycobacterium bovis Bacillus Calmette-Guerin.
Bakhtiyari S; Haghani K; Farhadi E; Soukhtanloo M; Rezaei N; Taghikhani M
Hybridoma (Larchmt); 2010 Jun; 29(3):211-5. PubMed ID: 20568995
[TBL] [Abstract][Full Text] [Related]
37. Antigen-specific lymphocytes enhance nitric oxide production in Mycobacterium bovis BCG-infected bovine macrophages.
Carpenter E; Fray L; Gormley E
Immunol Cell Biol; 1998 Aug; 76(4):363-8. PubMed ID: 9723778
[TBL] [Abstract][Full Text] [Related]
38. Infection with live mycobacteria inhibits in vitro detection of Ia antigen on macrophages.
Mshana RN; Hastings RC; Krahenbuhl JL
Immunobiology; 1988 Apr; 177(1):40-54. PubMed ID: 3133306
[TBL] [Abstract][Full Text] [Related]
39. Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages.
Sypek JP; Jacobson S; Vorys A; Wyler DJ
Infect Immun; 1993 Sep; 61(9):3901-6. PubMed ID: 8359912
[TBL] [Abstract][Full Text] [Related]
40. No evidence for antibodies to mycobacterial A60 antigen in Crohn's disease sera by enzyme-linked immunoabsorbent assay (ELISA).
McFadden JJ; Houdayer C
J Med Microbiol; 1988 Apr; 25(4):295-8. PubMed ID: 3282074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
